Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results
Provided By PR Newswire
Last update: Aug 14, 2025
PRINCETON, N.J., Aug. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended June 30, 2025.
Read more at prnewswire.comNASDAQ:SNGX (8/25/2025, 11:34:34 AM)
3.3
-0.08 (-2.37%)
Find more stocks in the Stock Screener
SNGX Latest News and Analysis
